[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BG102182A - The use of ipriflavon for reducing the number of cd8+ cells - Google Patents

The use of ipriflavon for reducing the number of cd8+ cells

Info

Publication number
BG102182A
BG102182A BG102182A BG10218298A BG102182A BG 102182 A BG102182 A BG 102182A BG 102182 A BG102182 A BG 102182A BG 10218298 A BG10218298 A BG 10218298A BG 102182 A BG102182 A BG 102182A
Authority
BG
Bulgaria
Prior art keywords
ipriflavon
cells
reducing
selectivesuppression
isopropoxyisophalon
Prior art date
Application number
BG102182A
Other languages
Bulgarian (bg)
Inventor
Attila B.Kovacs
Peter Aranyi
Terezia Kerepesi
Gyoergy Varai
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of BG102182A publication Critical patent/BG102182A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention relates to a pharmaceutical compositionapplicable in human and veterinary medicine for selectivesuppression of the CD8+ lymphocytes. The composition is preparedby known methods and contains 7-isopropoxyisophalon as activeingredient and suitable inert, solid or liquid carriers,optionally the usual therapeutical additives and auxialiarycompositions.4 claims
BG102182A 1995-07-21 1998-01-14 The use of ipriflavon for reducing the number of cd8+ cells BG102182A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
BG102182A true BG102182A (en) 1998-08-31

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102182A BG102182A (en) 1995-07-21 1998-01-14 The use of ipriflavon for reducing the number of cd8+ cells

Country Status (22)

Country Link
EP (1) EP0841915A1 (en)
JP (1) JP2001503371A (en)
KR (1) KR19990028933A (en)
CN (1) CN1191483A (en)
AR (1) AR002905A1 (en)
AU (1) AU6367096A (en)
BG (1) BG102182A (en)
BR (1) BR9610187A (en)
CA (1) CA2227421A1 (en)
CZ (1) CZ2798A3 (en)
EA (1) EA199800146A1 (en)
EE (1) EE9800020A (en)
HR (1) HRP960345A2 (en)
HU (1) HU9502198D0 (en)
IL (1) IL122751A0 (en)
MX (1) MX9800603A (en)
NO (1) NO980127L (en)
PL (1) PL324460A1 (en)
SK (1) SK3298A3 (en)
WO (1) WO1997003664A1 (en)
YU (1) YU42796A (en)
ZA (1) ZA966079B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (en) * 1990-03-23 1993-12-29 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
JP2001503371A (en) 2001-03-13
KR19990028933A (en) 1999-04-15
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
MX9800603A (en) 1998-04-30
PL324460A1 (en) 1998-05-25
NO980127D0 (en) 1998-01-12
EE9800020A (en) 1998-08-17
HU9502198D0 (en) 1995-09-28
EA199800146A1 (en) 1998-08-27
CZ2798A3 (en) 1998-06-17
NO980127L (en) 1998-01-12
EP0841915A1 (en) 1998-05-20
AU6367096A (en) 1997-02-18
ZA966079B (en) 1998-01-19
YU42796A (en) 1999-03-04
CA2227421A1 (en) 1997-02-06
IL122751A0 (en) 1998-08-16
SK3298A3 (en) 1998-07-08
BR9610187A (en) 1998-07-28
AR002905A1 (en) 1998-04-29
HRP960345A2 (en) 1998-02-28
CN1191483A (en) 1998-08-26

Similar Documents

Publication Publication Date Title
NZ221224A (en) Cyrstalline (4r,5s,6s,8r,2's,4's)--4-mehept-2-en-7-one-2-carboxylic acid and pharmaceutical comp
IL84315A0 (en) Hydrogenated phenylbenzopyrans,their preparation and pharmaceutical compositions containing them
ZA928771B (en) Combination chemotherapy
UA37244C2 (en) Method for treating or preventing clinical disorders curable with progesterone in female patients
IL76932A0 (en) Pharmaceutical compositions containing dihydrocodeine and ibuprofen
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
MY115662A (en) Novel compounds with analgesic effect
ITMI922953A1 (en) DOUBLE BIOLOGICAL ACTIVITY OF NO SYNTHASIS AND CYCLOOXYGENES PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM.
ZA874635B (en) Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation
AU7554087A (en) Pharmaceutical composition with analgesic activity
EG18379A (en) Novel pharmacological compounds
EP1535929A3 (en) Megakaryocyte stimulating factors
AU7672587A (en) Compositions for parenteral administration and their use
MC1915A1 (en) Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them
EP0663835A1 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
IL81833A0 (en) Renin inhibitors,their preparation and pharmaceutical compositions containing them
NZ230155A (en) N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions
AU8164287A (en) 3-(w-(3,5-di-t-butyl-4-hydroxyphenyl)- alkanoyl)pyrroles, their de-oxy analogs, and therapeutic uses thereof
BE902796A (en) ESTER OF ACETYL CARNITINE, ITS PREPARATION AND ITS USE.
IL83412A (en) 5',5'-disubstituted 2',5'-dideoxyuridines and 2',5'-dideoxycytidines,their preparation and pharmaceutical compositions containing them
BG102182A (en) The use of ipriflavon for reducing the number of cd8+ cells
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
AU2798689A (en) Oral dosage units for pharmaceuticals and their use and preparation
ES8704903A1 (en) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine-N-oxide and medical compositions using it.